CSRxP Statement On The Trump Administration’s Proposal To Change Medicare Drug Prices

Oct 25, 2018

For Immediate Release:
Contact: Lauren Blair
(201) 213-5004
[email protected]

The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement in response to the U.S. Department of Health and Human Services’ (HHS) new proposal regarding Medicare drug prices:

“We’re pleased to see that the Trump Administration continues to focus on lowering out-of-control drug prices for all Americans, including seniors and other patients who get their medications through the Medicare program. As drug companies continue to rake in record profits and fewer Americans are able to afford the treatments they need, we appreciate the administration exploring innovative approaches that disrupt the status quo.

“As we learn more about the details of this proposal, it will be critical for the administration and Congress to continue focusing on market-based solutions that strengthen transparency and boost competition – essential ingredients to making drugs more affordable.”


About the Campaign for Sustainable Rx Pricing
The Campaign for Sustainable Rx Pricing (CSRxP) is a broad-based coalition of leaders – physicians, nurses, hospitals, consumers, health plans, PBMs, pharmacists, and businesses – promoting bipartisan, market-based solutions to lower drug prices in America.